Continuous intrajejunal infusion of levodopa-carbidopa (DrugBank: Carbidopa, Levodopa)
8 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
2 | 筋萎縮性側索硬化症 | 0 |
4 | 原発性側索硬化症 | 0 |
6 | パーキンソン病 | 1 |
17 | 多系統萎縮症 | 0 |
90 | 網膜色素変性症 | 0 |
140 | ドラベ症候群 | 0 |
164 | 眼皮膚白皮症 | 0 |
201 | アンジェルマン症候群 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02480803 (ClinicalTrials.gov) | December 2014 | 4/5/2015 | INfusion VErsus STimulation in Parkinson's Disease | Treatment in Advanced Parkinson's Disease: Continuous Intrajejunal Levodopa INfusion VErsus Deep Brain STimulation | Parkinson's Disease | Drug: Continuous intrajejunal infusion of levodopa-carbidopa;Device: deep brain stimulation | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | ZonMw: The Netherlands Organisation for Health Research and Development | Recruiting | 18 Years | N/A | All | 66 | Phase 4 | Netherlands |